UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Should All Donors Be Treated by Ex Vivo Lung Perfusion?-Reply

JAMA surgery, 2020-06, Vol.155 (6), p.535

2020

Volltextzugriff (PDF)

De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation

American journal of respiratory and critical care medicine, 2016-09, Vol.194 (5), p.596-606

2016

Volltextzugriff (PDF)

Intragraft donor-specific antibodies and lung transplantation

The European respiratory journal, 2019-11, Vol.54 (5), p.1901937

2019

Volltextzugriff (PDF)

Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion

JAMA surgery, 2019-12, Vol.154 (12), p.1143

2019

Volltextzugriff (PDF)

Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.547-556

2015

Volltextzugriff (PDF)

Inhibition of Vascular Endothelial Growth Factor Receptors 1 and 2 Attenuates Natural Killer Cell and Innate Immune Responses in an Experimental Model for Obliterative Bronchiolitis

The American journal of pathology, 2022-02, Vol.192 (2), p.254-269

2022

Volltextzugriff (PDF)

Critical Role of VEGF-C/VEGFR-3 Signaling in Innate and Adaptive Immune Responses in Experimental Obliterative Bronchiolitis

The American journal of pathology, 2012-11, Vol.181 (5), p.1607-1620

2012

Volltextzugriff (PDF)

Enhanced flux pinning isotropy by tuned nanosized defect network in superconducting YBa2Cu3O6+x films

Scientific reports, 2019-10, Vol.9 (1), p.1-12, Article 15425

2019

Volltextzugriff (PDF)

Implications of High Sensitivity Troponin Levels After Lung Transplantation

Transplant international, 2024-04, Vol.37, p.12724-12724

2024

Volltextzugriff (PDF)

Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation — a retrospective single‐center cohort study

Transplant international, 2021-01, Vol.34 (1), p.62-75

2021

Volltextzugriff (PDF)

Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients—a single‐center retrospective cohort study

Transplant international, 2019-09, Vol.32 (9), p.965-973

2019

Volltextzugriff (PDF)

The fraction of sensitization among lung transplant recipients in a transplant center in Japan

BMC pulmonary medicine, 2020-10, Vol.20 (1), p.1-256, Article 256

2020

Volltextzugriff (PDF)

Donor Simvastatin Treatment Abolishes Rat Cardiac Allograft Ischemia/Reperfusion Injury and Chronic Rejection Through Microvascular Protection

Circulation (New York, N.Y.), 2011-09, Vol.124 (10), p.1138-1150

2011

Volltextzugriff (PDF)

Extending cytomegalovirus prophylaxis in high‐risk (D+/R−) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective study

Transplant infectious disease, 2020-08, Vol.22 (4), p.e13277-n/a

2020

Volltextzugriff (PDF)

Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo

American journal of respiratory cell and molecular biology, 2013-04, Vol.48 (4), p.448-455

2013

Volltextzugriff (PDF)

Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse

The Journal of heart and lung transplantation, 2016-05, Vol.35 (5), p.671-678

2016

Volltextzugriff (PDF)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation

Radiation oncology (London, England), 2018-08, Vol.13 (1), p.142-142, Article 142

2018

Volltextzugriff (PDF)

Intra-subject variability in oscillometry correlates with acute rejection and CLAD post-lung transplant

Frontiers in medicine, 2023-05, Vol.10, p.1158870-1158870

2023

Volltextzugriff (PDF)

The Association Between Extravascular Lung Water and Critical Care Outcomes Following Bilateral Lung Transplantation

Transplantation direct, 2022-10, Vol.8 (10), p.e1376-e1376

2022

Volltextzugriff (PDF)

Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts

The Journal of heart and lung transplantation, 2011-06, Vol.30 (6), p.707-716

2011

Volltextzugriff (PDF)

Iron oxide nanocomposite magnets produced by partial reduction of strontium hexaferrite

EPJ Web of conferences, 2014-01, Vol.75, p.4007-1-04007-4

2014

Volltextzugriff (PDF)

Effect of simvastatin on development of obliterative airway disease: An experimental study

The Journal of heart and lung transplantation, 2012-02, Vol.31 (2), p.194-203

2012

Volltextzugriff (PDF)

Tacrolimus Treatment Effectively Inhibits Progression of Obliterative Airway Disease Even at Later Stages of Disease Development

The Journal of heart and lung transplantation, 2008-08, Vol.27 (8), p.856-864

2008

Volltextzugriff (PDF)

Role of Platelet-derived Growth Factor and Vascular Endothelial Growth Factor in Obliterative Airway Disease

American journal of respiratory and critical care medicine, 2006-11, Vol.174 (10), p.1145-1152

2006

Volltextzugriff (PDF)

Natural course and risk factors for impaired renal function during the first year after heart transplantation

The Journal of heart and lung transplantation, 2010-06, Vol.29 (6), p.633-640

2010

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(106)
Japanisch
(11)
Finnisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(85)
Transplantation
(40)
Humans
(39)
Male
(38)
Surgery
(37)
Respiratory System
(31)
Animals
(28)
Biological And Medical Sciences
(27)
Lung Transplantation
(26)
Medical Sciences
(25)
Female
(24)
Cardiovascular System & Cardiology
(21)
Middle Aged
(21)
Cardiac & Cardiovascular Systems
(19)
Rats
(18)
Retrospective Studies
(16)
Adult
(15)
Lung Transplantation - Adverse Effects
(15)
Immunology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Should All Donors Be Treated by Ex Vivo Lung Perfusion?-Reply

De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation

Intragraft donor-specific antibodies and lung transplantation

Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion

Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation

Inhibition of Vascular Endothelial Growth Factor Receptors 1 and 2 Attenuates Natural Killer Cell and Innate Immune Responses in an Experimental Model for Obliterative Bronchiolitis

Critical Role of VEGF-C/VEGFR-3 Signaling in Innate and Adaptive Immune Responses in Experimental Obliterative Bronchiolitis

Enhanced flux pinning isotropy by tuned nanosized defect network in superconducting YBa2Cu3O6+x films

Implications of High Sensitivity Troponin Levels After Lung Transplantation

Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation — a retrospective single‐center cohort study

Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients—a single‐center retrospective cohort study

The fraction of sensitization among lung transplant recipients in a transplant center in Japan

Donor Simvastatin Treatment Abolishes Rat Cardiac Allograft Ischemia/Reperfusion Injury and Chronic Rejection Through Microvascular Protection

Extending cytomegalovirus prophylaxis in high‐risk (D+/R−) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective study

Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo

Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation

Intra-subject variability in oscillometry correlates with acute rejection and CLAD post-lung transplant

The Association Between Extravascular Lung Water and Critical Care Outcomes Following Bilateral Lung Transplantation

Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts

Iron oxide nanocomposite magnets produced by partial reduction of strontium hexaferrite

Effect of simvastatin on development of obliterative airway disease: An experimental study

Tacrolimus Treatment Effectively Inhibits Progression of Obliterative Airway Disease Even at Later Stages of Disease Development

Role of Platelet-derived Growth Factor and Vascular Endothelial Growth Factor in Obliterative Airway Disease

Natural course and risk factors for impaired renal function during the first year after heart transplantation

Suchergebnisse filtern